RNA for Precision Medicine – EVis Bioscience on Fortune Italia
We are pleased to share a new feature about EVis Bioscience AG published by Fortune Italia, highlighting how our technology is helping shape the future of precision medicine based on RNA therapeutics.
The article explores the scientific vision behind EVis: developing advanced non-viral delivery systems capable of directing therapeutic RNA safely and selectively to specific organs. This platform aims to overcome the limitations of current technologies and pave the way toward more effective treatments for rare diseases.
It also outlines the origins of the company, the international background of our CTO, Prof. Elita Montanari, and the path that led to the development of our novel RNA delivery strategy.
We invite you to read the full article to learn more about how EVis Bioscience is contributing to the evolution of advanced therapies:
➡️ RNA for Precision Medicine – Discovering EVis Bioscience AG (Fortune Italia)
